Alignment Healthcare’s chief experience officer sells $129,255 in stock

Hakan Kardes, the Chief Experience Officer at Alignment Healthcare, Inc. (NASDAQ:ALHC), recently sold a portion of his holdings in the company. According to a recent SEC filing, Kardes sold 7,225 shares of the company’s common stock. The shares were sold at a weighted-average price of $17.89, resulting in a total transaction value of approximately $129,255. The transaction comes as ALHC trades near its 52-week high of $18.44, having delivered an impressive return of 269% over the past year. InvestingPro analysis indicates the stock is currently trading above its Fair Value.

The sale was necessary to cover tax withholding obligations related to the vesting of restricted stock units and was not a discretionary trade by Kardes. Following this transaction, Kardes retains ownership of 678,987 shares in the company. The company’s market capitalization currently stands at $3.5 billion, with revenue growing at 48% year-over-year.

Alignment Healthcare, headquartered in Orange, California, is a provider of healthcare services and plans, and its stock trades under the ticker ALHC on the NASDAQ exchange. While the company maintains a moderate debt level and strong current ratio of 1.88, InvestingPro subscribers have access to 12 additional key insights about ALHC’s financial health and growth prospects through the comprehensive Pro Research Report.

In other recent news, Alignment Healthcare reported impressive fourth-quarter 2024 earnings, surpassing analysts’ expectations with an EPS of -0.16 against a forecast of -0.18. Revenue also exceeded projections, reaching $701.2 million compared to the anticipated $674.97 million. The company achieved its first year of adjusted EBITDA profitability, marking a significant milestone. Piper Sandler and Raymond (NSE:RYMD) James both raised their price targets for Alignment Healthcare, to $21 and $19 respectively, reflecting confidence in the company’s growth potential. Piper Sandler maintained an Overweight rating, citing the company’s scalable processes and high Star Ratings as key success factors. Raymond James highlighted the company’s robust performance, noting a membership growth of 59% and a lower-than-expected medical loss ratio. Alignment Healthcare’s revenue guidance for 2025 is set between $3.72 billion and $3.78 billion, with projected membership growth to 227,000-233,000 members. The company’s expansion beyond California, particularly in Nevada, contributed to its growth trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.